Haemonetics

Haemonetics is a blood management firm that offers devices, software and consulting services for the blood supply chain. Read more

1,450 Followers on Owler
1,450 Followers on Owler
1,450 Followers on Owler
1,450 Followers on Owler

Haemonetics

Haemonetics is a blood management firm that offers devices, software and consulting services for the blood supply chain. Read more

Christopher Simon's photo - President & CEO of Haemonetics

President & CEO

Christopher Simon

CEO Approval Rating

55/100

Founded:

1971

Status:

PublicIndependent CompanyNYSEHAE

HAEMONETICS TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Terumo BCT is the top competitor of Haemonetics. Terumo BCT was founded in 1964, and its headquarters is in Lakewood, Colorado. Terumo BCT is in the Pharmaceuticals field. Terumo BCT has 3,784 more employees than Haemonetics.

Fresenius is seen as one of Haemonetics's top competitors. Fresenius was founded in Bad Homburg, Hesse} in 1912. Like Haemonetics, Fresenius also works within the Health Care Services industry. Compared to Haemonetics, Fresenius generates $43.7B more revenue.

Macopharma SA is Haemonetics's #3 rival. Macopharma SA's headquarters is in Tourcoing, Nord-Pas-de-Calais, and was founded in 1977. Macopharma SA operates in the Medical Research & Laboratories industry. Macopharma SA generates 27% of Haemonetics's revenue.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Philips a competitor of Haemonetics?

Haemonetics Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$883.9M

Haemonetics's revenue is the ranked 15th among it's top 10 competitors. The top 10 competitors average 11.2B. Over the last three quarters, Haemonetics's revenue has grown by 22.9%. Specifically, in Q4 2020's revenue was $240.4M; in Q3 2020, it was $209.5M; in Q2 2020, it was $195.6M.

Haemonetics Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Cardiva Medical, Inc.

Jan 2021

Source »
$475M
Cardiva Medical is a medical device company that develops vascular access management products for interventional endovascular procedures.

-

enicor GmbH

Apr 2020

Source »
undisclosed
-

-

Transfusion Medicine Business, Pall Corporation

Aug 2012

Source »
$550M
-

-

Blood Collection Unit, SEBRA

Sep 2009

Source »
$12.5M
-

-

TEG Thrombelastograph

Nov 2007

Source »
$44M
-

These are all the companies that Haemonetics has acquired. Haemonetics has acquired 7 companies and its latest acquisition was Cardiva Medical, Inc. in Jan 2021. Cardiva Medical is a medical device company that develops vascular access management products for interventional endovascular procedures.

Haemonetics Funding History

ROUND

FUNDING DATE

AMOUNT

INVESTORS

IPO
May 1991
--

Since Haemonetics was founded in 1971, it has participated in 1 round of funding. In total Haemonetics has raised $0. Haemonetics' funding round was on May 1991 for a total of $0

Haemonetics Investments

No recent investments found related to Haemonetics

These are all the companies that Haemonetics has invested in. Haemonetics has invested 7 companies and its latest investment was Cardiva Medical, Inc. in Jan 2021. Cardiva Medical is a medical device company that develops vascular access management products for interventional endovascular procedures.

Haemonetics News

April 19, 2021Benzinga

Why Haemonetics's Stock is Trading Lower Today

The Price And Volume Action In Haemonetics's Stock TodayHaemonetics (NYSE:HAE) is currently down 30.5... See more »
March 18, 2021Global Legal Chronicle

Haemonetics' $435 Million Convertible Notes Offering

Latham & Watkins LLP represented the initial purchasers in the offering. Haemonetics Corporation (NYS... See more »
March 3, 2021BioSpace

Haemonetics Prices $435.0 Million Convertible Senior Notes Offering

Haemonetics Corporation ("Haemonetics") (NYSE: HAE) today announced the pricing of its offering of $4... See more »
February 26, 2021Markets Insider

Haemonetics To Present At The Jefferies Plasma Summit

BOSTON, Feb. 26, 2021 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon,... See more »
February 2, 2021MarketScreener

rsquo; Acquisition of Cardiva Medical

(marketscreener.com) Haemonetics' Acquisition of Cardiva Medical February 2, 2021 © 2021 Haemonetics ... See more »
January 22, 2021Markets Insider

Haemonetics Says Supports FDA Guidance On Viscoelastic Testing During COVID-19 Pandemic

(RTTNews) - Haemonetics Corp. (HAE) said Friday it supports new guidance issued by the U.S. Food and ... See more »
January 20, 2021Boston Real Estate Times

Hilco Selects Erland Construction to Update Former Haemonetics Headquarters in Braintree

BRAINTREE, MA - Hilco Redevelopment Partners has selected Erland Construction to replace the existing... See more »

Haemonetics Press Releases

September 12, 2019PR Newswire

Haemonetics Appoints Stewart W. Strong As President, Global Hospital

BRAINTREE, Mass., Sept. 12, 2019 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medica... See more »
February 5, 2019CentralCharts

Haemonetics 3rd Quarter Fiscal 2019 Earnings Release Available on Investor Relations Website

Haemonetics Corporation (NYSE:HAE) announced that its third quarter and year-to-date fiscal 2019 resu... See more »
December 20, 2018PR Newswire

Haemonetics to Present at 37th Annual J.P. Morgan Healthcare Conference

BRAINTREE, Mass., Dec. 20, 2018 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Ch... See more »
December 19, 2018Centralcharts

Haemonetics Corporation/

Haemonetics Announces Headquarters Relocation To Boston, issued 19-Dec-2018 by Haemonetics Corporatio... See more »
August 7, 2018PR Newswire

Haemonetics Appoints Josep Lluis Llorens As Senior Vice President, Global Manufacturing And Supply Chain

BRAINTREE, Mass., Aug. 7, 2018 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) today announced th... See more »
July 19, 2018StreetInsider

August 7, 2018

Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish first quarter fisca... See more »
June 18, 2018StreetInsider

Haemonetics Completes Debt Refinancing With Five-Year Senior Unsecured Credit Facilities

Haemonetics Corporation (NYSE: HAE) announced that the Company has entered into a new $700 million cr... See more »

Social Media

Haemonetics Headquarters

400 Wood Road

Braintree, Massachusetts02184

781-848-7100

Driving Directions »

Trending Companies

Haemonetics Summary

ABOUT

Overview

Haemonetics is a blood management firm that offers devices, software and consulting services for the blood supply chain. Haemonetics was founded in 1971. Haemonetics' headquarters is located in Braintree, Massachusetts, USA 02184. It has raised undisc...

CEO

Haemonetics's President & CEO, Christopher Simon, currently has an approval rating of 55%. Haemonetics's primary competitors are Terumo BCT, Fresenius & Macopharma SA.

Website

haemonetics.com

Frequently Asked Questions about Haemonetics

  1. When was Haemonetics founded?

    Haemonetics was founded in 1971
  2. Who is Haemonetics's CEO?

    Haemonetics's CEO is Christopher Simon
  3. How much revenue does Haemonetics generate?

    Haemonetics generates $883.9M in revenue
  4. How much funding does Haemonetics have?

    Haemonetics has historically raised $0 in funding
  1. Where is Haemonetics's headquarters?

    Haemonetics's headquarters is in Braintree Massachusetts, USA
  2. How many employees does Haemonetics have?

    Haemonetics has 3,216 employees
  3. What sector does Haemonetics operate in?

    Haemonetics is in Health Care Facilities, Health Care Services
  4. Who are Haemonetics's competitors?

    Haemonetics's top competitors are Terumo BCT, Fresenius, Macopharma SA